title: Development of plumbagin-loaded phospholipid-Tween® 80 mixed micelles: formulation, optimization, effect on breast cancer cells and human blood/serum compatibility testing.
abstract: BACKGROUND
  Phospholipid and Tween(®) 80 mixed micelles were investigated as injectable nanocarriers for the natural anticancer compound, plumbagin (PBG), with the aim to improve anticancer efficiency. PBG-loaded mixed micelles were fabricated by self-assembly; composition being optimized using 3(2) factorial design.
  
  
  CONCLUSIONS
  Optimized mixed micelles were spherical and 46 nm in size. Zeta potential, drug loading and encapsulation efficiency were 5.04 mV, 91.21 and 98.38% respectively. Micelles demonstrated sustained release of PBG. Micelles caused a 2.1-fold enhancement in vitro antitumor activity of PBG towards MCF-7 cells. Micelles proved safe for intravenous injection as PBG was stable at high pH; micelle size and encapsulation efficiency were retained upon dilution.
  
  
  CONCLUSIONS
  Developed mixed micelles proved potential nanocarriers for PBG in cancer chemotherapy.
authors.affiliation: Department of Pharmaceutics, Poona College of Pharmacy, Bharati Vidyapeeth University, Erandwane, Pune 411038, Maharashtra, India.
authors.forename: Chellampillai
authors.initials: C
authors.lastname: Bothiraja
authors.forename: Harshad S
authors.initials: HS
authors.lastname: Kapare
authors.forename: Atmaram P
authors.initials: AP
authors.lastname: Pawar
authors.forename: Karimunnisa S
authors.initials: KS
authors.lastname: Shaikh
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D001798:Blood Proteins / Q000378:metabolism; D001943:Breast Neoplasms / Q000473:pathology*; D002470:Cell Survival / Q000187:drug effects; D002626:Chemistry, Pharmaceutical; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D004355:Drug Stability; D005260:Female; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D007700:Kinetics; D061986:MCF-7 Cells; D008823:Micelles; D053758:Nanoparticles; D036103:Nanotechnology; D009285:Naphthoquinones / Q000008:administration & dosage / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D010316:Particle Size; D010743:Phospholipids / Q000737:chemistry* / Q000378:metabolism / Q000633:toxicity; D011136:Polysorbates / Q000737:chemistry* / Q000378:metabolism / Q000633:toxicity; D011485:Protein Binding; D012995:Solubility; D013678:Technology, Pharmaceutical / Q000379:methods
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D001798:Blood Proteins; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D008823:Micelles; D009285:Naphthoquinones; D010743:Phospholipids; D011136:Polysorbates; C014758:plumbagin